A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2006
10/18/2006	CN1849141A Spacer moiety for poly(ethylene glycol)-modified peptide- based compounds
10/18/2006	CN1849140A Bitterness-masking particulate jelly beverage
10/18/2006	CN1849114A Topical preparations comprising a hydrophilic carrier and a silicone matrix
10/18/2006	CN1849111A Ophthalmic composition for contact lens
10/18/2006	CN1849110A Novel injectable depot formulations
10/18/2006	CN1847285A Polyoxyethylene ligand containing coupler and its synthesis process
10/18/2006	CN1847259A Preparation of a therapeutic composition
10/18/2006	CN1847252A Prepn process and medicinal composition of amorphous Adefovir dipivoxil
10/18/2006	CN1846790A Injected tissue engineering bone and its constrction and application
10/18/2006	CN1846789A Injected bone repairing material and its prepn and application
10/18/2006	CN1846788A Prepn process of nanometer carboxymethyl chitosan particle as medicine carrier
10/18/2006	CN1846787A Eye gel and its prepn process
10/18/2006	CN1846710A Vagina cleaning agent
10/18/2006	CN1846702A Dispersed cefditoren pivoxil tablet and its prepn process
10/18/2006	CN1846700A Slow-released 5-fluorouracil system in vitreous chamber
10/18/2006	CN1846691A Long circulation liposome with modified integrin and carried anticancer medicine for injection
10/18/2006	CN1846689A Slow-released anticancer prepn containing taxane and its synergist
10/18/2006	CN1846688A Slow-released anticancer prepn containing taxane and its synergist
10/18/2006	CN1846687A Slow-released prepn containing taxane and its synergist
10/18/2006	CN1846686A Slow-released injection containing taxol and its synergist
10/18/2006	CN1846685A Slow-released injection containing bendamustine and its synergist
10/18/2006	CN1846684A Slow-released injection containing methotrexate synergist
10/18/2006	CN1846683A Slow-released injection containing methotrexate synergist
10/18/2006	CN1846682A Slow-released anticancer prepn containing methotrexate
10/18/2006	CN1846681A Slow-released injection containing methotrexate and its synergist
10/18/2006	CN1846680A Slow-released methotrexate injection
10/18/2006	CN1846679A Slow-released injection containing methotrexate and its synergist
10/18/2006	CN1846678A Slow-released anticancer injection
10/18/2006	CN1846677A Slow-released injection containing fluoroplex synergist
10/18/2006	CN1846676A Slow-released injection containing fluoroplex synergist and its prepn process
10/18/2006	CN1846675A Slow-released anticancer medicine prepn containing 5-Fu synergist
10/18/2006	CN1846674A Slow-released anticancer medicine injection
10/18/2006	CN1846673A Slow-released anticancer medicine prepn containing pyrimidine medicine
10/18/2006	CN1846672A Anticancer medicine composition containing antimetabolite
10/18/2006	CN1846671A Oral solution containing alfacalcidol
10/18/2006	CN1846670A Anticancer implant
10/18/2006	CN1846669A Sustained release of peptides from pharmaceutical compositions
10/18/2006	CN1280298C Diol containing phosphatidylcholine and use thereof
10/18/2006	CN1279981C 5-CNAC as oral delivery agent for parathyroid hormone fragments
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279937C Antiseptic and insect killing washing liquid and preparing method
10/18/2006	CN1279916C 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds
10/18/2006	CN1279914C Minoxidil-containing preparations
10/18/2006	CN1279899C Process for producing granules containing branched amino acids
10/18/2006	CN1279893C Surfactant compounds and uses thereof
10/18/2006	CN1279891C Use of water solution containing positive ion cellulose polymer in preparation of drug for treating dry eye
10/18/2006	CA2503099A1 Pharmaceutical compositions containing camptothecins
10/17/2006	US7122664 Cucurbituril-fullerene complex
10/17/2006	US7122618 Cosmetics, drugs, plant safening agents, microbiocides, textiles
10/17/2006	US7122602 Process of making polymeric hydrogels by reactive extrusion
10/17/2006	US7122579 Eye treatments using synthetic thyroid hormone compositions
10/17/2006	US7122553 Liposomal formulation of irinotecan
10/17/2006	US7122528 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
10/17/2006	US7122525 Targeted therapeutics and uses thereof
10/17/2006	US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
10/17/2006	US7122353 For use in cancer therapy
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122213 Composed of squash extract mixed with onion extract, having hypotensive effect and an anti-diabetic effect
10/17/2006	US7122206 Spraying into nose; triamcinolone acetonide
10/17/2006	US7122205 Bioerodable polymeric adhesives for tissue repair
10/17/2006	US7122201 Parental administration of promethazine, including promethazine hydrochloride, along with one or more nonionic surfactants and at least one amino acid and/or one polyol
10/17/2006	US7122189 Releasable polymeric conjugates based on aliphatic biodegradable linkers
10/17/2006	US7122184 Monoclonal antibody for use in prevention of fungal infections
10/17/2006	US7122143 Methods for manufacturing dosage forms
10/17/2006	CA2489140C Dosage form containing pantoprazole as active ingredient
10/17/2006	CA2294744C Multiple unit effervescent dosage form
10/17/2006	CA2250318C Sustained-release metal valproate tablets
10/17/2006	CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/17/2006	CA2182981C Sublingual or buccal pharmaceutical composition
10/17/2006	CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
10/14/2006	CA2504076A1 Degradeable elastomeric network
10/12/2006	WO2006108052A2 Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
10/12/2006	WO2006107903A2 Polymeric micelles for drug delivery
10/12/2006	WO2006107598A2 Conjugates of photoactive compound and a bulking group for enhancing photodynamic therapy
10/12/2006	WO2006107357A1 Improved formulations of fenofibrate containing menthol or a peg/poloxamer mixture
10/12/2006	WO2006107330A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
10/12/2006	WO2006107316A1 Improved formulations of fenofibrate containing menthol or peg/poloxamer
10/12/2006	WO2006107009A1 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
10/12/2006	WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
10/12/2006	WO2006106923A1 Disintegrating tablet in oral cavity and process for producing the same
10/12/2006	WO2006106889A1 Methods of producing sodium alginate-containing tablet and tablets obtained by the production methods
10/12/2006	WO2006106805A1 Method of improving the storage stability of substance
10/12/2006	WO2006106799A1 Microcapsule using polyvinyl alcohol copolymer
10/12/2006	WO2006106705A1 Oil/fat-containing composition for suppression of cancer development
10/12/2006	WO2006106528A1 Novel peptides useful for treatment of alopecia
10/12/2006	WO2006106521A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
10/12/2006	WO2006106519A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/12/2006	WO2006106435A2 Fusion protein comprising a hiv nef double mutant and its use therapy
10/12/2006	WO2006106398A1 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
10/12/2006	WO2006106103A2 Prevention of hiv- infection with tmc278
10/12/2006	WO2006106023A1 Hydroxydeoxybenzoins and the use thereof to mask a bitter taste
10/12/2006	WO2006105993A2 Method for shielding functional sites or epitopes on proteins
10/12/2006	WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis
10/12/2006	WO2006105659A1 Hydrophilic core polymeric micelles for the delivery of water-soluble compounds
10/12/2006	WO2006105630A1 A cosmetic composition, a pharmaceutical composition and a process for preparing said compositions
10/12/2006	WO2006105615A1 Buccal delivery system
10/12/2006	WO2006066868A3 Sustained release formulation comprising bisphosphonate
10/12/2006	WO2006062807A3 Compositions with enhanced immunogenicity
10/12/2006	WO2006059221A3 Topical hydro-alcoholic formulations of oxazolidinone antibacterial agents
10/12/2006	WO2006005667A3 Polypeptide protracting tags comprising a tetrazole moiety

1 ... 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 ... 1712